Bridgeway Capital Management’s Lyra Therapeutics LYRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $540K | Sell |
|
|||||
|
2023
Q4 | $743K | Hold |
|
|||||
|
2023
Q3 | $554K | Buy |
|
|||||
|
2023
Q2 | $398K | Sell |
|
|||||
|
2023
Q1 | $304K | Hold |
|
|||||
|
2022
Q4 | $461K | Buy |
|
|||||
|
2022
Q3 | $285K | Hold |
|
|||||
|
2022
Q2 | $321K | Sell |
|
|||||
|
2022
Q1 | $269K | Hold |
|
|||||
|
2021
Q4 | $292K | Sell |
|
|||||
|
2021
Q3 | $630K | Buy |
|
|||||
|
2021
Q2 | $336K | Sell |
|
|||||
|
2021
Q1 | $568K | Hold |
|
|||||
|
2020
Q4 | $559K | Buy |
|